Concepedia

Author

Hugh Laverty

University of Manchester

Also Known As

Hugh G. Laverty, Hugh Laverty, Laverty, Hugh Gerard

30

Publications

1.6K

Citations

12

H-Index

30

Concepts

All Affiliations

University of ManchesterRenovo (United Kingdom)University of Glasgow
HL

About

Hugh Laverty is an author at University of Manchester specializing in medicine, data management, and stem cell therapies.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

426

2

Engineering

1

1

11

3

Cell Biology

1

1

38

4

Cellular Therapies

1

1

12

5

Data Science

1

1

11

Hugh Laverty

×

9

Publications

661

Citations

9

H-Index

YearCitations

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

Mark W. J. Ferguson, Jonathan Duncan, Jeremy S. Bond,

The Lancet

2009

296

Diet Restriction Inhibits Apoptosis and HMGB1 Oxidation and Promotes Inflammatory Cell Recruitment during Acetaminophen Hepatotoxicity

Daniel J. Antoine, Dominic P. Williams, Anja Kipar,

Molecular Medicine

2010

103

Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring

Nick L. Occleston, Sharon O’Kane, Hugh Laverty,

Wound Repair and Regeneration

2011

78

Murine CASK Is Disrupted in a Sex-Linked Cleft Palate Mouse Mutant

Hugh Laverty, Joanna B. Wilson

Genomics

1998

69

A synthetic gene increases TGFβ3 accumulation by 75‐fold in tobacco chloroplasts enabling rapid purification and folding into a biologically active molecule

Martin F. Gisby, Philip Mellors, Panagiotis Madesis,

Plant Biotechnology Journal

2011

43

Mapping and expression analysis of the human CASK gene

David Stevenson, Hugh Laverty, Sandra V. C. T. Wenwieser,

Mammalian Genome

2000

38

Assessing the Safety of Stem Cell Therapeutics

Christopher E. Goldring, Paul Duffy, Nissim Benvenisty,

Cell stem cell

2011

12

The European lead factory—an experiment in collaborative drug discovery

Hugh Laverty, Kristina M. Orrling, Fabrizio Giordanetto,

JOURNAL OF MEDICINES DEVELOPMENT SCIENCES

2015

11

‘Big Data’ in Pharmaceutical Science: Challenges and Opportunities

Al G. Dossetter, Gerhard F. Ecker, Hugh Laverty,

Future Medicinal Chemistry

2014

11

Page 1